OUR PIPELINE

Bavituximab

Antibody to phosphatidylserine (PS)1

0%

Navicixizumab

Antibody to VEGF-A and DLL4

0%

Varisacumab

Antibody to VEGF-A2

0%
Regional License

Lefitolimod3

TLR9 Agonist

0%

1 Indirectly binds PS through beta-2 glycoprotein 1 (β2-GP1)
2 Selectively antagonizes binding to the activating receptor VEGFR-2

OUR PIPELINE